The close proximity of the Precinct Partners has been key to building a culture of collaboration over many years.
Melbourne has biomedical capabilities unparalleled in Australia and amongst the world’s best. We are home to an exceptional network of skilled workers, quality education providers, leading research institutes and a sophisticated health system.
The Melbourne Biomedical Precinct has a rich history over 160 years.
There are also established partnerships within the Melbourne Biomedical Precinct with global health institutions including the World Health Organization (WHO), the Bill & Melinda Gates Foundation, American Foundation for AIDS Research, National Institutes of Health and The Wellcome Trust.
Neurosciences, including mental health, is one of the pillars of research excellence in the Melbourne Biomedical Precinct. There is a strong translational thread running through the program, bringing the science out of the research institutes and into the community, hospitals, clinics and patients.
The multi-site, multi-disciplinary VCCC Alliance aims to reduce the burden of cancer in the community by creating an international centre of research, clinical care and teaching excellence.
The Melbourne Biomedical Precinct’s expertise in child health provides a critical mass for generating and translating research that improves children’s lives across the globe.
The work of the Melbourne Biomedical Precinct represents internationally recognised themes that improve quality of life, prevent disease and manage cardiovascular, hearing, vision and musculoskeletal health into later life.
Digital health and clinical informatics represent the integration of digital technologies into all levels of health research and the provision of health care, from understanding the causes of disease and streamlining the way doctors and hospitals work, through to incorporating genomics and big data into our understanding of health and disease.
The human genome is our blueprint for life. It contains all the information needed for us to grow and develop, consisting of 3.2 billion ‘letters’ of DNA and over 20,000 ‘chapters’ in the form of individual genes. Genomic medicine seeks to read and analyse our genome to gain insights into how each of us is different, as well as understand the causes of malfunction and disease.
In contrast to pharmaceutical small molecule drugs, cell and biological therapies use substances made from living organisms to treat disease. These substances may occur naturally in the body or be made in the laboratory.
The Melbourne Biomedical Precinct is building on its existing strengths across the breadth of the research and commercialisation pipeline to become one of the world’s top drug discovery centres.
The Melbourne Biomedical Precinct is at the forefront of stem cell research in Australia and is uniquely positioned to capitalise on the coming age of regenerative medicine, with applications to tackle a range of rare and common diseases.
The Melbourne Biomedical Precinct has a long history of leadership in immunology. Melbourne Biomedical Precinct researchers are developing new vaccines and therapies to prevent, treat and cure diseases that affect Australians, along with hundreds of millions of people across the globe.
The Melbourne Biomedical Precinct is ready to capitalise on the spectacular growth in medical devices and implantables that are changing the lives of patients who have limited treatment options. This offers potential to spark a new advanced manufacturing industry in Victoria.
By understanding and addressing the complex causes of disease, we can promote smart policies that help keep people healthy, productive and out of hospital. This will improve the wellbeing of Victorians and reduce the burden of disease on the healthcare system.
A Precinct approach to collaboration and innovation